BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CG009301 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of CG009301\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07347171-2889@assetmemo.bio
DTSTAMP:20261121T005441Z
DTSTART;VALUE=DATE:20271230
DTEND;VALUE=DATE:20271231
SUMMARY:CG009301: Phase 1 readout est. (NCT07347171)
DESCRIPTION:CG009301\, phase 1\, Acute Myeloid Leukemia.\nStudy: A Phase 1 
 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refrac
 tory Haematological Malignancies\nEstimated primary completion: 30 Decembe
 r 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/cg009301#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07347171
URL:https://assetmemo.bio/drug/cg009301#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
